#glomerular
Atypical Anti–Glomerular Basement Membrane Disease With Dual Positivity for Anti-α3(IV) Noncollagenous 1 and Antiperlecan Antibodies: A Case Report - Kidney International Case Reports www.kicasereports.org/article/S311...

#KICR highlights
Atypical Anti–Glomerular Basement Membrane Disease With Dual Positivity for Anti-α3(IV) Noncollagenous 1 and Antiperlecan Antibodies: A Case Report
A 54-year-old man presented with hypertension, progressive renal dysfunction, hematuria, nephrotic-range proteinuria, and hypoalbuminemia. Standard commercial assays for anti–glomerular basement membrane (GBM) antibodies showed weak positivity. Renal biopsy demonstrated linear IgG deposition along the glomerular capillary wall and crescentic glomerulonephritis with crescents at various stages of evolution and prominent endocapillary hypercellularity. Given the discrepancy between serological and pathological findings, indirect immunofluorescence confirmed circulating anti-GBM antibodies, and subsequent testing with human recombinant antigens at Peking University First Hospital revealed strong positivity for both anti-α3(IV)noncollagenous 1 (NC1) and antiperlecan (heparan sulfate proteoglycan 2 [HSPG2]) antibodies.
www.kicasereports.org
November 18, 2026 at 7:34 PM
Focal segmental glomerulosclerosis (FSGS) is a nonspecific pattern of glomerular scarring in which a subset of the glomeruli show partial involvement of the glomerular tuft. It should not be confused for a specific disease.
November 17, 2026 at 5:30 PM
Textbook example of IF staining in anti-brush border antibody disease. Granular IgG proximal tubular BM, BC, and brush border staining and segmental glomerular capillary deposits. An LRP2 stain (not pictured) was positive in the deposits. #renalpath #pathsky #nephsky
November 21, 2026 at 11:35 PM
The ISN is thrilled to be attending CCSN 2026 and hosting its Primer Course in Glomerular Diseases in Shanghai, welcoming 100 participants from across China.
November 17, 2026 at 2:00 PM
➡️ From podocyte biology to glomerular medicine: The 15th International Podocyte Conference 2025 www.kidney-internati...
November 19, 2026 at 4:00 PM
The authors included RRIDs in their in Journal of Cellular Physiology paper! Thanks for making your methods matter! #reproducibility #methodsmatter #BetterScience
Mapping of PTP1B, TCPTP, SHP2, and Putative Substrates Reveals Novel Networks in Glomerular Podocytes
Read the full paper: Mapping of PTP1B, TCPTP, SHP2, and Putative Substrates Reveals Novel Networks in Glomerular Podocytes
doi.org
November 20, 2026 at 8:01 AM
Integrated analysis of laser-captured glomerular proteome characterizes the expression and functional role of APOE in membranous nephropathy #NeuroDegeneration 🧪🧠
https://www.researchsquare.com/article/rs-11227389/latest
November 19, 2026 at 5:03 PM
Integrated analysis of laser-captured glomerular proteome characterizes the expression and functional role of APOE in membranous nephropathy #SingleCell 🧪🧬🖥️
https://www.researchsquare.com/article/rs-11227389/latest
November 19, 2026 at 5:01 PM
ASN's Glomerular Diseases Collaborative is advancing care through education, collaboration, and practical resources that support earlier diagnosis, timely referral, and access to treatment for people living with glomerular diseases. #ASNEpc
Read more in #ASNKidneyNews kidney.pub/Kn1811-15
November 16, 2026 at 6:28 PM
Exciting news! ISGD joins NKF and NephCure in a new KidneyCARE Study partnership to amplify patient voices and advance glomerular disease research.

Read the announcement: www.kidney.org/press-room/n...
November 18, 2026 at 7:53 PM
Have a glomerular disease case you’d value input on? Present a case from your practice and hear perspectives from the Hub Team and peers at NKF’s Project ECHO.

Explore the series and register: bit.ly/4zrc3KE

#ProjectECHO #Nephrology
November 18, 2026 at 8:03 PM
Open Access UCL Research: Absence of glomerular IgA1 deposition despite overexpression of galactose-deficient IgA1 in the B cell c1galt1 knockout mouse
discovery.ucl.ac.uk/id/eprint/10...
November 16, 2026 at 10:21 AM
🩻 Can routine CT estimate kidney function?

🔬 In 139 patients, CT-derived glomerular filtration rate showed the lowest estimation error compared with conventional blood-based equations.
November 13, 2026 at 1:05 PM
💡 CT-based renal function assessment could support clinical decision-making, including chemotherapy planning and kidney donor evaluation.

link.springer.com/article/10.1... (Kristoffer Huitfeldt Sola et al.)
Estimation of glomerular filtration rate by standard renal CT imaging - Insights into Imaging
Objectives To develop and evaluate a method to predict glomerular filtration rate (GFR) from clinical renal CT. Materials and methods Medical records of adult living kidney donors operated between…
link.springer.com
November 13, 2026 at 1:05 PM
Join NKF’s free, virtual Evidence to Action: Glomerular Disease Project ECHO. Learn with kidney care colleagues on the third Tuesday of each month, Jan–Jun 2027, 2–3 p.m. ET.

For more information and to register: www.kidney.org/project-echo...

#Nephrology #ProjectECHO
November 14, 2026 at 4:02 PM
Low-proteinuric diabetic kidney disease with sustained rapid kidney function decline is associated with endothelial and tubular transcriptional alterations without uniform advanced glomerular filtration-barrier lesions, finds a study in Cardiovascular Diabetology.

#MedSky
Single-cell profiling identifies endothelial and tubular transcriptional alterations associated with rapid kidney function decline in low-proteinuric diabetic kidney disease - Cardiovascular Diabetology
Background Some patients with diabetic kidney disease (DKD) experience rapid loss of kidney function despite minimal proteinuria; however, the cellular and pathological features associated with this phenotype remain unclear. In this study, we aimed to characterize the cell-specific transcriptional and pathological alterations associated with sustained rapid kidney function decline in low-proteinuric DKD. Methods We performed single-cell RNA sequencing of kidney biopsy specimens from three patients with low-proteinuric DKD with sustained rapid kidney function decline (DKD-RD), defined by a urinary protein-to-creatinine ratio < 0.15 g/g creatinine, an absolute estimated glomerular filtration rate (eGFR) slope < − 5 mL/min/1.73 m2/year, and an annual relative eGFR decline > 10% over at least 2 years. Non-diabetic kidney tissues from two nephrectomy specimens served as controls. Donor-level pseudobulk differential-expression and pathway analyses were integrated with histopathological and ultrastructural findings. We also conducted an exploratory comparison with a published classical/proteinuric DKD dataset. Results Analysis of 35,352 cells showed lower expression of genes related to endothelial differentiation, vascular integrity, and vascular development in DKD-RD, accompanied by higher NOX4 expression and reactive oxygen species-related programs. Tubular cells exhibited segment-specific remodeling, characterized by increased expression of CUBN and LRP2 in proximal tubular cells alongside reduced expression of several sodium-dependent solute transporter genes. Glomerular lesions were mild and heterogeneous; electron microscopy showed focal endothelial abnormalities in some cases, while podocyte foot processes were largely preserved. Immune cell analysis revealed no evidence of a uniform inflammatory activation state. Comparison with a published classical/proteinuric DKD dataset showed limited concordance in disease-associated transcriptional patterns. Conclusions Low-proteinuric DKD with sustained rapid kidney function decline is associated with endothelial and tubular transcriptional alterations without uniform advanced glomerular filtration-barrier lesions. These findings raise the possibility that this phenotype has a transcriptional profile distinct from that of classical/proteinuric DKD, although confirmation in larger cohorts is needed. Graphical abstract
bit.ly
November 15, 2026 at 7:09 PM
Gaps in Glomerular Disease Clinical Trials — Where Are We Today?

Spectacular talks by Brad Rovin, Marina Vivarelli and Jonathan Barratt! 🌟

#CTS2026 #ISGD #GlomerularDisease #ClinicalTrials #Nephrology
@Tobias B. Huber @The University of Texas Medical Branch
November 13, 2026 at 6:51 PM
Kidney tissue from 106 patients shows semaglutide repairing glomerular blood vessels and silencing inflammatory genes

#Biology #Innovation
Kidney tissue from 106 patients shows semaglutide repairing glomerular blood vessels and silencing inflammatory genes
Science News
buzmedia.ir
November 12, 2026 at 5:47 AM
Fibrillary glomerulopathy is a rare glomerular disease traditionally defined by the presence of haphazardly arranged large fibrils measuring 10 to 30 nm in thickness in the glomerular mesangium by electron microscopy. The immunofluorescence characteristically shows smudgy mesangial staining for IgG.
November 10, 2026 at 5:00 PM
Join healthcare professionals for this new virtual series featuring expert insights, case-based discussions, and practical strategies for glomerular disease care—designed for the entire healthcare team.

For more information and to register: bit.ly/4zrc3KE
November 12, 2026 at 9:02 PM
Most cases of fibrillary glomerulopathy are Congo-red negative. A recent report by Nasr, et al. describes an immunohistochemical stain that is likely to transform the diagnosis of this entity. In this report, positive glomerular staining for DNAJB9 had a 98% sensitivity and...
November 10, 2026 at 5:00 PM
“Ravulizumab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial.”
Publié ce jour dans le @nejm.org .
#MedSky #NephSky
www.nejm.org/doi/full/10....
Ravulizumab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial | NEJM
In patients with IgA nephropathy, complement activation drives glomerular inflammation, which leads to hematuria, proteinuria, and nephron loss. Ravulizumab is a terminal complement inhibitor that ...
www.nejm.org
November 12, 2026 at 3:44 PM
#ScientificSessions26 - Treatment with dapagliflozin improves estimated #glomerular filtration rate over a 12-month period in adult patients who have received #HeartTransplantation.

https://bit.ly/4zAnQqD
Dapagliflozin Demonstrates Renal Benefits Among Heart Transplant Recipients - The Cardiology Advisor
Researchers evaluated the safety and efficacy of dapagliflozin vs placebo for renal protection in adult heart transplant recipients.
www.thecardiologyadvisor.com
November 10, 2026 at 11:22 PM